The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Have my occasional grumpy moments sean but wouldnt still be invested after nearly 2 years if I wasnt still positive. Seen a few ups and downs in that time but I believe in the managements abilities and alignment with shareholders. We just need a visit from lady luck.
Gggg21..."HT test only used on Roche machines."
Would be good if you could provide your source for that info or retract it. As far as I know, Novacyt tests are designed to be used on as many machines as possible.
Im sure the government bought the tests from us..after all were a business not a charity. Likely we sold them at a hefty discount, hence the free publicity. All good advertising and hopefully will lead to more orders..if we still have the capacity left
Didnt mean to sound too pessimistic..just dissapointed at the late start to the drilling as were already a month or two into the dry season but then again we are in the middle of a serious pandemic and also I was building my hopes up for some big news. At least were less of a gamble now as weve already got C East in the bag. (Worth more than present sp on its own and lots more targets to go at. Probably be range bound for a while until more significant news but whats new. Theres lots of potential good news to come and lets hope by around November, December well be much closer to the end game that everyone is waiting for. Fwiji is a very promising target, so looking forward to some good drill results there.
8,000 metres divided by say an average of 160 metres is still 50 holes, if we have time to drill it all before the rains start.
Its a strong hold for me.
I think its fair to say that most were hoping for something more substantial than that. What this does for the sp short term I hate to think.
Here goes for another season (5 to 6 months now remaining) lets hope we can find something substantial and those massive sulphides eventually arrive.
Sp is up and down like a pair of slack elastic underpants.
Best not to spend too much time watching it. Just think about what it will be in a few months with revenue in the hundreds of millions and unfortunately no sign of covid going away.
Thanks for the heads up on the ncyt board Robinson. Have to keep one eye here now
There was also a saying in xfiles... "The truth is out there but so are lies"
Its usually easy enough to sift one from the other with a bit of common sense though.
This from back in April...
"The CNR (Centre National de Référence des Virus des Infections Respiratoires) of the Institut Pasteur has approved Novacyt's COVID-19 test.
The internationally renowned centre for biomedical research's approval is joined by the Ministry of Health in Thailand.
The Company's CE-Mark test is available for immediate distribution into the French market.
Graham Mullis, CEO of Novacyt, said: "As an Anglo-French company, I am delighted that Novacyt is able to support both of its domestic markets in tackling this pandemic.
The Institut Pasteur's evaluation and approval of our COVID-19 test is an important validation and I am grateful to Atothis, our distribution partner in France, for its efforts in working with the centre. We look forward to supporting the French authorities in their COVID-19 testing requirements."
The Primerdesign COVID-19 test has received accreditation from a number of leading global regulatory authorities, including Public Health England and the US Food and Drug Administration.
In addition to the test currently being approved in the UK, the US, France, India, the Philippines, Argentina and Thailand, it is available in markets which directly accept CE-Mark accreditation without the need for further approval."
It can and im sure "is" being used in private clinics in France, so if the voucher is for private clinics then end of debate as far as im concerned but as has been said, uptake in France wont make a lot of difference anyway, since were selling into over 130 countries.
Whats important is overall sales and well soon get the latest figures.
No it wasnt..its still there. Should be more careful using the board when tired.
Gives those who didnt see the article first time round a chance to have a read anyway : )
This article below.
Its important to us as investors in a rival covid 19 test to know, so not off topic and wasnt abusive. Maybe it was a mistake to criticise the UK government and call for an independent inquiry into their handling of the covid health crisis but it is relevant.
Maybe if i avoid using the words Tory, bungling, Covid, wasteful and inquiry in the same sentence it will be ok.
It would be good for all if they followed expert medical advice more closely and used the appropriate tests instead of looking for a cheap or quick fix.
https://news.sky.com/story/amp/coronavirus-warning-over-covid-19-antibody-tests-given-to-nhs-and-care-workers-12014343
A group of senior medical experts has raised concerns about coronavirus antibody tests being carried out on NHS and care staff.
The blood tests - described by Prime Minister Boris Johnson as potentially "game-changing" - can tell whether a person has had COVID-19 in the past.
The government purchased 10 million test kits from pharmaceutical giant Abbott and Roche last month, with the first phase of the testing programme assessing NHS and care workers.
But in a letter published by the British Medical Journal, a group of academics and clinicians have voiced concerns about the performance of the tests and warned they risk "inefficient use of scarce resources".
They said that a positive or negative test result would not alter the management of a patient and added that a positive result "does not indicate immunity".
"The concept of 'immune passports', allowing healthcare workers or others to work, has not been established," they wrote.
"Those with a positive antibody test should still consider themselves at risk and follow infection control policies…. There is, therefore, no benefit to healthcare organisations or to others in knowing the status of employees at present."
The experts say the tests are being rolled out "at an unprecedented pace and scale without adequate assessment".
There is also currently no data showing the performance of tests in people at high risk including the elderly and those in black and minority ethnic groups, they add.
NHS England requires the results of antibody tests to be available within 24 hours.
But the academics warn: "Given that routine testing of patients is neither clinically urgent nor meets a clear public health need, this push to introduce a non-evidence based test for uncertain gains risks inefficient use of scarce resources."
They concluded that the "only current justification" for large-scale COVID-19 antibody testing is "for research purposes".
The letter is signed by 14 medical experts including Dr Monique Andersson, consultant in infection at Oxford University Hospitals; Neil French, professor of infectious diseases and global health at the University of Liverpool; and Deenan Pillay, professor of virology at University College London.
We dont know it but If there has been financial gain for politicians or their family/friends from these 10m inneffective tests then its a national scandal. Im sure any wrongdoing would be difficult to prove but an "independent" inquiry should be instigated.
of Tory bungling? Wasting much needed funds on innacurate and unnecessary tests.
Just came across this Sky news article. Apologies if its already been posted
https://news.sky.com/story/amp/coronavirus-warning-over-covid-19-antibody-tests-given-to-nhs-and-care-workers-12014343
A group of senior medical experts has raised concerns about coronavirus antibody tests being carried out on NHS and care staff.
The blood tests - described by Prime Minister Boris Johnson as potentially "game-changing" - can tell whether a person has had COVID-19 in the past.
The government purchased 10 million test kits from pharmaceutical giant Abbott and Roche last month, with the first phase of the testing programme assessing NHS and care workers.
But in a letter published by the British Medical Journal, a group of academics and clinicians have voiced concerns about the performance of the tests and warned they risk "inefficient use of scarce resources".
They said that a positive or negative test result would not alter the management of a patient and added that a positive result "does not indicate immunity".
"The concept of 'immune passports', allowing healthcare workers or others to work, has not been established," they wrote.
"Those with a positive antibody test should still consider themselves at risk and follow infection control policies…. There is, therefore, no benefit to healthcare organisations or to others in knowing the status of employees at present."
The experts say the tests are being rolled out "at an unprecedented pace and scale without adequate assessment".
There is also currently no data showing the performance of tests in people at high risk including the elderly and those in black and minority ethnic groups, they add.
NHS England requires the results of antibody tests to be available within 24 hours.
But the academics warn: "Given that routine testing of patients is neither clinically urgent nor meets a clear public health need, this push to introduce a non-evidence based test for uncertain gains risks inefficient use of scarce resources."
They concluded that the "only current justification" for large-scale COVID-19 antibody testing is "for research purposes".
The letter is signed by 14 medical experts including Dr Monique Andersson, consultant in infection at Oxford University Hospitals; Neil French, professor of infectious diseases and global health at the University of Liverpool; and Deenan Pillay, professor of virology at University College London.
Part 2
"Weve got the majors in the data room. Theyre doing their homework and theyre going to make their minds up over time. Theyre doing site visits and so on, so thats the other route to potentially developing this but our goal is not to bring a major in at the most depressed valuation and allow them to take control overnight. We can do that very easily but thats not the game."
Nvs
"I think they need more data sets, so we are working on that, we are working with them. They want to see the type of core. Theyre not necessarily interested in wether its 1% or 2%, thats not the priority, its really to see if were sitting on a bigger system in that area of Zambia."
"If nearology, in terms of whats next to us is anything to go by, lady luck will be with us and im a betting sort of guy and I think give us 1 to 2 years and I think well be sitting on something significant here."
NvS
"If we are sitting on something substantial and I think we are..we will be multiples of what we are today. What I can say is that the higher grade zones within Cheyeza East..if you look at that..and we are going to publish something next year on this. The value of that in my view is our share price today (about 2.8 pence), so to some extent you could say that all the rest is a free upside option on the 800 odd sq kilometres"
"Possibly have enough capital, with sale of Casa and Sturec to see us through to Q2"
Thats from the back end of last year so things have moved on a bit and you should see the vid. It gives a good sense of the possibilities we have with our massive licence area and majors sniffing around for a piece of the action.
Im sure most here have seen Nicks recent Crux interview but any new investors should check it out...
https://youtu.be/9zUk0ppGixY
About to watch it again to refresh my memory but heres a few notes I made at the time if anyone is interested to read...
Part 1
NvS
"We want to invest in exploration, 5 to 10 million dollars over the next 12 to 18 months, to really see what we have."
Asked how much do you have now? (Nov 2019)
NvS "Were good until early next year (2020) and then we have close to $2 million dollars, so were fine for the next few months and were working hard on plans, in terms of bringing in bigger amounts of capital from the right sorts of institutions and shareholders."
NvS
"We have signed now NDAs with 4 very large mining companies."
What for?
NvS
"To potentially come and acquire us or help develop us."
Is that your model?
NvS
"Not a model but if you have something interesting, you should be illiciting interest from the majors and in fact the reverse has happened...they have approached us. I mean i got a call when i was sitting in greece last summer..August, from a very large mining house that phoned me out of the blue and said these are the best exploration results out of Africa in the last decade"